A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors
Clinical trial NCT04393298 · COMPLETED
Trial details
- NCT number
- NCT04393298
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2024-04-11
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.